Clinical Trials - Cardiovascular Disease and HIV

• A5332: Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

  Study Location: BaltimoreIndia

  Eligibility: HIV infected men and women between the ages of 40 and 75 On HIV medications for at least 6 months CD4 cell count greater...

  Enrollment: Closed

  Read More

• A5314: Effect of LDMTX on Inflammation in HIV-infected Individuals

  Study Location: Baltimore

  Eligibility: HIV-infected men and women ≥40 years old, who have been virologically suppressed on continuous antiretroviral therapy for at...

  Enrollment: Closed

  Read More